The world's first safe analgesic passed preclinical trials
The world's first analgesic with no side effects has successfully passed the preclinical trials. The innovative drug was created by a scientific group that included specialists from TSU, IPCET SB RAS, and the Research Institute of Pharmacology and Regenerative Medicine named after E.D. Goldberg. The basis for the analgesic, which has no analogs, was the modified molecule of the powerful explosive CL-20.
- CL-20 or hexanitrohexaazaisowurtzitane (HNIW) is well known as the strongest high-energy substance, and in 2003 they began to try to use it for medical purposes, - says Alexander Vorozhtsov, TSU Vice-Rector for Research and Innovation Activities, Chief Researcher, IPCET SB RAS. - Using a computer simulation, a new molecule with the proposed activity of the analgesic was created. Using directed synthesis, we obtained a first-in-class substance. Preclinical studies have confirmed its unique medicinal properties.
Read more: http://en.tsu.ru/news/the-world-s-first-safe-analgesic-passed-preclinical-trials/
